212 related articles for article (PubMed ID: 33831328)
1. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
Marsili L; Bologna M; Jankovic J; Colosimo C
Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
[No Abstract] [Full Text] [Related]
2. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
3. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
Duarte GS; Rodrigues FB; Ferreira JJ; Costa J
Parkinsonism Relat Disord; 2018 Nov; 56():16-19. PubMed ID: 29910156
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.
Kongsaengdao S; Arayawithchanont A; Samintharapanya K; Rojanapitayakorn P; Maneeton B; Maneeton N
Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678987
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials.
Chinnapongse RB; Lew MF; Ferreira JJ; Gullo KL; Nemeth PR; Zhang Y
Clin Neuropharmacol; 2012; 35(5):215-23. PubMed ID: 22932474
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
Jochim A; Meindl T; Mantel T; Zwirner S; Zech M; Castrop F; Haslinger B
J Neurol; 2019 Aug; 266(8):1879-1886. PubMed ID: 31049731
[TBL] [Abstract][Full Text] [Related]
8. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study.
Hefter H; Samadzadeh S
Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888623
[TBL] [Abstract][Full Text] [Related]
10. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
11. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
Kessler KR; Skutta M; Benecke R
J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
15. Application of botulinum toxin in pregnancy and its impact on female reproductive health.
Li W; Tang M
Expert Opin Drug Saf; 2020 Jan; 19(1):83-91. PubMed ID: 31868020
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Factor SA; Molho ES; Evans S; Feustel PJ
Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
[TBL] [Abstract][Full Text] [Related]
17. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.
Schramm A; Bäumer T; Fietzek U; Heitmann S; Walter U; Jost WH
J Neural Transm (Vienna); 2015 Oct; 122(10):1457-63. PubMed ID: 25547861
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.
Ferreira JJ; Colosimo C; Bhidayasiri R; Marti MJ; Maisonobe P; Om S
Parkinsonism Relat Disord; 2015 Feb; 21(2):111-5. PubMed ID: 25499753
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]